Clinical trial Recruiting at 1 site Interventional Ages 60 and up

Cognitive Model for Behavioral Interventions to reduce behavioral and psychological symptoms in people with dementia

Official title: Examining the Efficacy of a Personalized Cognitive Model as Non-Pharmacological Intervention for Behavioral and Psychological Symptoms of Dementia

Run by Vrije Universiteit Brussel · NCT07356336 · Data updated 2026-11-12

This project will try a person-centered, non-drug program called CoMBI to see if it reduces behavioral and psychological symptoms in people with dementia living in nursing homes and eases caregiver burden.

Quick facts

Study typeInterventional
Ages60 Years and up
SexAll
Enrollment60 (estimated)
SponsorVrije Universiteit Brussel
Academic / other
Locations1 site (Tienen, Vlaams-Brabant)
StatusRecruiting
StartedFebruary 16, 2026
Main results expectedDecember 31, 2028
Study endsDecember 31, 2028
Registry record updatedAugust 20, 2026
Trial IDNCT07356336 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are nursing home residents with a formal diagnosis of neurocognitive disorder and at least one current behavioral or psychological symptom, with a Dutch-proficient primary caregiver and an informant available to provide premorbid personality information.

Probably not a fit

People without current BPSD, those not residing in participating nursing homes, or those lacking a Dutch-speaking caregiver or informant are unlikely to be eligible or benefit from this program.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study compares CoMBI, a person-centered non-pharmacological program grounded in Beck's cognitive model and nursing interventions, to usual care for nursing home residents with dementia who have one or more behavioral or psychological symptoms. CoMBI targets unmet core needs shaped by premorbid personality and environmental triggers and is delivered through individualized caregiver-led interventions in participating facilities. Outcomes include severity of behavioral and psychological symptoms (measured with the NPI-Q), caregiver burden, and quality of life, with additional analysis of whether personality, gender, cognitive level and dementia stage modify effects. The intervention is implemented in collaborating nursing homes and requires Dutch-proficient caregivers and informants for questionnaire completion.

Why it matters

Potential benefit: If successful, CoMBI could reduce BPSD, lower caregiver burden, and improve quality of life without adding medication-related risks.

How similar studies have gone: Previous non-pharmacological, person-centered interventions have shown mixed results, with some trials reducing BPSD and caregiver burden while others found limited effects, so CoMBI builds on promising but variable prior evidence.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Being a resident in a participating nursing home
* Having a formal diagnosis of neurocognitive disorder (NCD) accord-ing to DSM-5-TR (e.g. Alzheimer's disease, NCD with Lewy Bodies, Vascular NCD, …) or a medical record indicating probable dementia
* Presence of one or more BPSD symptoms at moment of inclusion in the study (measured with the NPI-Q at baseline). Symptoms measured by the NPI-Q include delusions, hallucinations, agitation/aggression, depression/dysphoria, anxiety, euphoria/elated mood, apathy/indifference, disinhibition, irritability/lability, aberrant motor behavior, nighttime behavior disturbances/sleep disturbances, and changes in appetite and eating behavior.
* Primary caregivers (i.e. nurses providing daily care) and patient's representative and/or a close relative/friend (i.e. informant who will fill in the premorbid personality questionnaire) are proficient in Dutch (i.e., are able to fill in the questionnaires)
* The informant who fills in the premorbid personality questionnaire knows the patient well from before the onset of neurocognitive problems
* As individuals with dementia are often legally incapacitated, informed consent will be obtained prior to participation from the resident when competent to consent, or otherwise from the resident's legal representative when legally incompetent.

Exclusion Criteria:

Exclusion criterion for nursing homes is:

\- Already applying a structured (theory-based) behavioral counseling as CAU.

Where it's running

  • Alexianen Zorggroep Tienen
    Tienen, Vlaams-Brabant, Belgium
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.